Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jesús Tornero Molina, Juan Carlos López Robledillo & Núria Casamira Ruiz. (2021) Potential Benefits of the Self-Administration of Subcutaneous Methotrexate with Autoinjector Devices for Patients: A Review. Drug, Healthcare and Patient Safety 13, pages 81-94.
Read now
Read now
Gino Antonio Vena, Nicoletta Cassano & Florenzo Iannone. (2018) Update on subcutaneous methotrexate for inflammatory arthritis and psoriasis. Therapeutics and Clinical Risk Management 14, pages 105-116.
Read now
Read now
Alfonso E Bello, Elizabeth L Perkins, Randy Jay & Petros Efthimiou. (2017) Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis. Open Access Rheumatology: Research and Reviews 9, pages 67-79.
Read now
Read now
Articles from other publishers (17)
Ning Tan, Chi‐Jen Hsu, Han‐You Mo, Xiuyan Yang & James Cheng‐Chung Wei. (2023) Methotrexate injection: An old drug with a newly developing landscape. International Journal of Rheumatic Diseases 26:12, pages 2366-2370.
Crossref
Crossref
Yoshiya Tanaka. (2023) Subcutaneous injection of methotrexate: Advantages in the treatment of rheumatoid arthritis. Modern Rheumatology 33:4, pages 633-639.
Crossref
Crossref
Varun Dhir, Chandra Bhushan Prasad, Sandeep Kumar, Kavya Kriti Kaul, Neha Dung, G. S. R. S. N. K. Naidu, Shefali K. Sharma, Aman Sharma & Sanjay Jain. (2023) Long-term persistence of oral methotrexate and associated factors in rheumatoid arthritis: a retrospective cohort study. Rheumatology International 43:5, pages 867-873.
Crossref
Crossref
Teresa Otón, Loreto Carmona, Estíbaliz Loza, María Piedad Rosario & Jose Luis Andreu. (2022) Use of parenteral methotrexate in rheumatic diseases: A systematic review. Reumatología Clínica (English Edition) 18:4, pages 207-226.
Crossref
Crossref
Teresa Otón, Loreto Carmona, Estíbaliz Loza, María Piedad Rosario & Jose Luis Andreu. (2022) Revisión sistemática del uso de metotrexato por vía parenteral en enfermedades reumáticas. Reumatología Clínica 18:4, pages 207-226.
Crossref
Crossref
Cécile Gaujoux-Viala, Christophe Hudry, Elena Zinovieva, Hélène Herman-Demars & René-Marc Flipo. (2022) MTX optimization or adding bDMARD equally improve disease activity in rheumatoid arthritis: results from the prospective study STRATEGE. Rheumatology 61:1, pages 270-280.
Crossref
Crossref
Arun Kumar Kedia, Kavitha Mohansundaram, Mohit Goyal & Vinod Ravindran. (2021) Safety of Long-Term Use of Four Common Conventional Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis. Journal of the Royal College of Physicians of Edinburgh 51:3, pages 237-245.
Crossref
Crossref
V.W.Y. Lai & R. Sinclair. (2020) Utility of azathioprine, methotrexate and cyclosporine as steroid‐sparing agents in chronic alopecia areata: a retrospective study of continuation rates in 138 patients. Journal of the European Academy of Dermatology and Venereology 34:11, pages 2606-2612.
Crossref
Crossref
Dawn Homer. (2019) Using video‐based training for button‐free auto‐injection of subcutaneous methotrexate: A pilot study. Musculoskeletal Care 17:3, pages 247-279.
Crossref
Crossref
Gouri M Koduri & Chetan Mukhtyar. (2019) Why subcutaneous methotrexate should be a prerequisite to biologic use in patients with rheumatoid arthritis. Rheumatology 58:4, pages 559-560.
Crossref
Crossref
Jesús Tornero Molina, Jaime Calvo Alen, Javier Ballina, María Ángeles Belmonte, Francisco J. Blanco, Miguel Ángel Caracuel, Jordi Carbonell, Héctor Corominas, Eugenio Chamizo, Cristina Hidalgo, José Román Ivorra, José Luis Marenco, José Vicente Moreno Muelas, Santiago Muñoz-Fernández, Joan M. Nolla, Trinidad Pérez, Raimon Sanmarti, Pilar Trenor, Claudia Urrego, Javier Vidal & José Rosas Gomez de Salazar. (2018) Recommendations for the Use of Parenteral Methotrexate in Rheumatic Diseases. Reumatología Clínica (English Edition) 14:3, pages 142-149.
Crossref
Crossref
Jesús Tornero Molina, Jaime Calvo Alen, Javier Ballina, María Ángeles Belmonte, Francisco J. Blanco, Miguel Ángel Caracuel, Jordi Carbonell, Héctor Corominas, Eugenio Chamizo, Cristina Hidalgo, José Román Ivorra, José Luis Marenco, José Vicente Moreno Muelas, Santiago Muñoz-Fernández, Joan M. Nolla, Trinidad Pérez, Raimon Sanmarti, Pilar Trenor, Claudia Urrego, Javier Vidal & José Rosas Gomez de Salazar. (2018) Recomendaciones sobre el uso de metrotexato parenteral en enfermedades reumáticas. Reumatología Clínica 14:3, pages 142-149.
Crossref
Crossref
Melanie K. Rohr, Ted R. Mikuls, Stanley B. Cohen, J. Carter Thorne & James R. O'Dell. (2017) Underuse of Methotrexate in the Treatment of Rheumatoid Arthritis: A National Analysis of Prescribing Practices in the US. Arthritis Care & Research 69:6, pages 794-800.
Crossref
Crossref
Michael H. Schiff & Peter Sadowski. (2016) Oral to subcutaneous methotrexate dose-conversion strategy in the treatment of rheumatoid arthritis. Rheumatology International 37:2, pages 213-218.
Crossref
Crossref
Glen S Hazlewood, J Carter Thorne, Janet E Pope, Daming Lin, Diane Tin, Gilles Boire, Boulos Haraoui, Carol A Hitchon, Edward C Keystone, Shahin Jamal & Vivian P Bykerk. (2016) The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis. Annals of the Rheumatic Diseases 75:6, pages 1003-1008.
Crossref
Crossref
Gerolamo Bianchi, Roberto Caporali, Monica Todoerti & Paolo Mattana. (2016) Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration. Advances in Therapy 33:3, pages 369-378.
Crossref
Crossref
Poonam Sharma & David G. I. Scott. (2015) Optimizing Methotrexate Treatment in Rheumatoid Arthritis: The Case for Subcutaneous Methotrexate Prior to Biologics. Drugs 75:17, pages 1953-1956.
Crossref
Crossref